A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study)

Hak Choy, Russell F. Devore, Kenneth R. Hande, Lester L. Porter, Paul Rosenblatt, Furhan Yunus, Larry Schlabach, Clyde Smith, Yu Shyr, David H. Johnson